Combination CurQD and Vedolizumab in Ulcerative Colitis
Combination CurQD and Vedolizumab in Ulcerative Colitis
Not yet recruiting · NCT07665294 · Registry updated 2026-10-05Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Combination CurQD and Vedolizumab in Ulcerative Colitis | Digestive System Diseases, colitis, colonic disorder, digestive system disorder, gastroenteritis, inflammatory bowel disease, intestinal disorder, ulcerative colitis | Not yet recruiting | Phase 4 | 2026-10-05 | NCT07665294 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Ryan C Ungaro | 1 |
| United States Department of Defense | 319 |
4 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CURVE-UC Icahn School of Medicine at Mount Sinai | New York | United States | 1 |
| CURVE-UC New York Gastroenterology Associates | New York | United States | 1 |
| Icahn School of Medicine at Mount Sinai | New York | United States | 342 |
| Sheba Medical Center | Ramat Gan | Israel | 43 |